Optimising TREATment for Severe Gram-Negative Bacterial Infections

NCT07004049 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

600

Enrollment

OTHER

Sponsor class

Conditions

Bloodstream Infection
Ventilator Associated Bacterial Pneumonia
Hospital Acquired Bacterial Pneumonia
Carbapenem Resistant Bacterial Infection
Multidrug Resistance

Interventions

DRUG: Colistin/Polymyxin B + Sulbactam
DRUG: Colistin/Polymyxin B + Tigecycline/Eravacycline
DRUG: Colistin/Polymyxin B + Meropenem
DRUG: Ceftazidime-avibactam + Sulbactam
DRUG: Ceftazidime-avibactam + Fosfomycin
DRUG: Ceftazidime-avibactam
DRUG: Ceftazidime-avibactam + Aztreonam
DRUG: Ceftazidime-avibactam + Colistin/Polymyxin B
DRUG: High-dose meropenem
DRUG: Meropenem + Fosfomycin
DRUG: Meropenem-vaborbactam
DRUG: Cefiderocol
DRUG: Ceftolozane-tazobactam
DRUG: Ceftolozane-tazobactam + Meropenem

Sponsor

National University of Singapore

Collaborators

[object Object]
[object Object]